KIR3DL1 and neoplasm: Such mismatch situations can occur either when endogenous NK cells encounter tumor cells that downregulated HLA or in the situation where patients receive donor NK cells that were selected based on the presence of a KIR-ligand mismatch to further potentiate NK cell anti-tumor responses.